Rational Development of a Novel Emulgel Adjuvant for Single‐Shot Effective Vaccination: A Multivariate Analysis Approach
Advanced Materials · 2025-08 · 37 (33)
DOI: 10.1002/adma.202506496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 03.06.2025. Verfasst von Ahmed O Shalash und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Vaccination, Adjuvants, Vaccine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nanoemulsions, like MF59, are potent vaccine adjuvants due to their immunogenicity, scalability, stability, and generation of broad cross‐clade neutralizing immune responses, facilitating their feasibility for pandemic preparedness. However, they are unsuitable for single‐shot applications due to limited immunogenicity with subunit antigens, and need to be explored for key immunogenic formulation variables like surfactant type, antigen anchoring, oil‐globule solidification, hydrogel polymer trapping, or globule size. Here, a multivariate analysis approach is used for the first time in adjuvant development, selecting 14 formulations from over 150, each with a unique formulation variable, to evaluate their immunological properties on C57BL/6 mice. Results show that nanoemulsions with hydrogel trapping, smaller globule size, or mannide monooleate cosurfactant significantly enhance immunogenicity, each by 5‐to‐10 folds over MF59. For the first time, these formulation variables are combined into an “optimized emulgel” that is predicted to maximize immunogenicity after a single shot, model fit gave ( R 2 = 0.97). The optimized emulgel triggers long‐lasting immune responses matching both the model's prediction and those triggered by the gold‐standard Freund's adjuvant against various antigens, while maintaining excellent safety. The findings highlight the potential of emulgels as a novel adjuvant class and underscore the utility of multivariate analysis in adjuvant design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD, 4072, Australia.
- School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Biological Resources, St Lucia, QLD, 4072, Australia.
ORCID-Profile: Ahmed O Shalash
Zitieren
APA
Shalash, A. O., Hussein, W. M., Nahar, U. J., Wang, J., Lu, L., Azuar, A., Kiong, J. J. E., Koirala, P., Khalil, Z. G., & Toth, I. (2025). Rational Development of a Novel Emulgel Adjuvant for Single‐Shot Effective Vaccination: A Multivariate Analysis Approach. Advanced Materials, 37(33). https://doi.org/10.1002/adma.202506496
Vancouver
Shalash AO, Hussein WM, Nahar UJ, Wang J, Lu L, Azuar A, et al. Rational Development of a Novel Emulgel Adjuvant for Single‐Shot Effective Vaccination: A Multivariate Analysis Approach. Advanced Materials. 2025;37(33). doi:10.1002/adma.202506496
BibTeX
@article{Shalash2025,
author = {Shalash, Ahmed O and Hussein, Waleed M and Nahar, Ummey J and Wang, Jingwen and Lu, Lantian and Azuar, Armira and Kiong, Jolynn J E and Koirala, Prashamsa and Khalil, Zeinab G and Toth, Istvan},
title = {Rational Development of a Novel Emulgel Adjuvant for Single‐Shot Effective Vaccination: A Multivariate Analysis Approach},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {33},
doi = {10.1002/adma.202506496}
}
EUVIMED